UPC APP 47172/2024

Aug 14, 2024·EP3666797 · ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Case details: Status
Written Phase
Action
Generic
Category
File-access requests (R. 262.1(b))
Parties: Claimants
Dehns
Representatives
John Somerton-Dehns
Respondents
Sanofi-Aventis Deutschland GmbHOperating co.
Amgen Inc.Operating co.
Representatives
Daniel Wise-Carpmaels & Ransford
Koen Bijvank-Brinkhof
Division: Munich CD
Judges: Ulrike Voß
András Kupecz
Casper Struve
Technology: Chemistry
Biotechnology · Pharmaceuticals
Language: English
First decided: Oct 22, 2024
EPO Opposition: Sanofi-Aventis Deutschland GmbHAdmissible2023-11-10
REGENERON PHARMACEUTICALS, INC.Admissible2024-02-19
Sanofi-Aventis Groupe S.A.Withdrawn2023-11-10
Sanofi Winthrop Industrie S.A.Withdrawn2023-11-10

How this compares

How long the court takes to reach a first decision.

	Median days to first decision
All UPC	124
Munich CD	Locked
Judge Ulrike Voß	Locked
Judge András Kupecz	Locked
Judge Casper Struve	Locked

At the UPC: Dehns (0 cases)·Sanofi Group (33 cases)

Related cases

More cases: Munich CD·2024

Documents

Document title	Date	Public
Procedural Order App_47172/2024	2024-10-23	Not public
Headnote-and-Keywords	2024-10-22	Not public
Outcome of the Order	2024-10-22	Not public
262.1(b) order	2024-10-22	Not public
262.1(b) order	2024-10-22	Public
Template-Order	2024-10-22	Not public
opportunity to comment for applicant	2024-09-10	Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed	2024-08-29	Not public
US Delaware District Court Memorandum Order	2024-08-29	Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed	2024-08-29	Not public